Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple”

36,793 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36,793 results

Testing effectiveness (Phase 2)WithdrawnNCT05170789
What this trial is testing

Elotuzumab, Selinexor, and Dexamethasone for Relapsed Refractory Multiple Myeloma

Who this might be right for
Relapsed Multiple MyelomaRefractory Multiple Myeloma
Tulane University School of Medicine
Testing effectiveness (Phase 2)Study completedNCT00239174
What this trial is testing

Study to Evaluate the Efficacy and Safety of of Four Doses of SR147778 in Obese Patients

Who this might be right for
Obesity
Sanofi 394
Not applicableLooking for participantsNCT06440174
What this trial is testing

Understanding the Variation of Modern Endoscopic Ultrasound Use in Patients With Oesophageal Cancer (VALUE)

Who this might be right for
Oesophageal Cancer
University Hospital Southampton NHS Foundation Trust 160
Not applicableUnknownNCT03612518
What this trial is testing

An mHealth Trial to Promote the Use of Postpartum Contraception

Who this might be right for
Contraception Behavior
Junaid-ur-Rehman Siddiqui 970
Early research (Phase 1)UnknownNCT02200718
What this trial is testing

NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Immune Response BioPharma, Inc. 12
Not applicableStudy completedNCT03257410
What this trial is testing

Theranova 400 Dialyzer In End Stage Renal Disease (ESRD) Patients

Who this might be right for
End Stage Renal Disease
Vantive Health LLC 172
Testing effectiveness (Phase 2)Looking for participantsNCT06561360
What this trial is testing

Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)

Who this might be right for
Hairy Cell Leukemia
Memorial Sloan Kettering Cancer Center 86
Early research (Phase 1)WithdrawnNCT06533280
What this trial is testing

VH3739937 Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers Including Relative Bioavailability (RBA), Optional Food Effect (FE), and Drug-drug Interaction (DDI)

Who this might be right for
HIV Infections
ViiV Healthcare
Testing effectiveness (Phase 2)Ended earlyNCT01023880
What this trial is testing

Study to Determine the Maximum Tolerated Dose and Evaluate the Efficacy and Safety of CEP-18770 (Delanzomib) in Patients With Relapsed Multiple Myeloma Refractory to the Most Recent Therapy

Who this might be right for
Multiple Myeloma
Cephalon 62
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07040280
What this trial is testing

Testing the Effect of Sulforaphane, a Compound Naturally Found in Cruciferous Vegetables, on Preventing Melanoma in Patients With a Prior History of Melanoma

Who this might be right for
Melanoma
Eastern Cooperative Oncology Group 120
Early research (Phase 1)Not Yet RecruitingNCT07113496
What this trial is testing

RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies

Who this might be right for
Relapsed or Refractory B-cell Hematologic MalignanciesB-cell Acute Lymphoblastic Leukemia (B-ALL)Multiple Myeloma (MM)+3 more
The First Affiliated Hospital with Nanjing Medical University 27
Very early researchEnded earlyNCT02653196
What this trial is testing

A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors

Who this might be right for
Neuroepithelial TumorSolid TumorAllogeneic Hematopoietic Stem Cell Transplantation
Montefiore Medical Center 1
Not applicableLooking for participantsNCT05258396
What this trial is testing

Exploring Cortical Remyelination in Children With Multiple Sclerosis

Who this might be right for
Children With Multiple Sclerosis
Assistance Publique - Hôpitaux de Paris 40
Early research (Phase 1)Looking for participantsNCT02203903
What this trial is testing

Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies

Who this might be right for
Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS
Catherine Bollard 50
Post-approval studies (Phase 4)UnknownNCT02576327
What this trial is testing

A Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
Vomiting
Jun Zhu 130
Large-scale testing (Phase 3)Looking for participantsNCT06927986
What this trial is testing

Phase III Trial of SYS6010 Versus Platinum-based Chemotherapy for EGFR-mutated NSCLC（SYNSTAR01）

Who this might be right for
EGFR-mutated Locally Advanced or Metastatic NSCLC
CSPC Megalith Biopharmaceutical Co.,Ltd. 380
Not applicableStudy completedNCT03650569
What this trial is testing

Italian Angelman Syndrome Registry

Who this might be right for
Angelman Syndrome
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS 82
Not applicableNot Yet RecruitingNCT07370935
What this trial is testing

Trunk Stability, Balance, and Fatigue in Minimally to Moderately Disabled People With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Cappadocia University 64
Not applicableStudy completedNCT06900335
What this trial is testing

Functional Connectome in Prader-Willi Syndrome: Neuroimaging and AI to Assess Therapeutic Impact

Who this might be right for
Prader Willi SyndromeHyperphagiaBehavior Disorders
Corporacion Parc Tauli 101
Early research (Phase 1)Ended earlyNCT00351325
What this trial is testing

BMS-663513 Administered in Combination With Chemotherapy to Subjects With Advanced Solid Malignancies

Who this might be right for
Advanced Solid Malignancies
Bristol-Myers Squibb 45
Load More Results